Introduction
All mature blood cells are derived from a small number of stem cells which, in the adult, are resident in the bone marrow [l] . These stem cells have two features that distinguish them from other haemapoietic cells. First, is their ability to undergo prolonged, perhaps indefinite, self-renewal. Secondly, is their potential to undergo differentiation to produce at least nine different types of mature cells: neutrophils, eosinophils, basophils, megakaryocytes, T-and B-lymphocytes, erythrocytes, monocytes and osteoclasts [2] . During this development, the pluripotent stem cells produce progeny that become progressively restricted in their choice of developmental options. Most of these committed progenitor cells can be recognized by their ability to undergo proliferation and development in uitro to produce clones of the appropriate mature cell type(s) , and include multipotent cells restricted to the myeloid cell lineages [colony-forming cells (mixed); CFC-Mix] ; primitive erythroid progenitor cells [burst-forming units (erythroid); BFUEl; and progenitor cells restricted to the granulocyte/macrophage (GM-CFC), eosinophil (Eos-CFC), megakaryocyte (Meg-CFC) and mastcell lineages. In contrast to the pluripotent stem cells, the progenitor cells possess little or no ability to undergo self-renewal (at least during normal 'steady-state' haemopoiesis). Since, in addition, the vast majority of the mature cells (produced from the progenitor cells) are destined to live for only a few hours (in the case of granulocytes), or a few weeks (erythrocytes), adequate production of mature blood cells can only be achieved by the continuous production of the progenitor cells from the small pool of stem cells [6] .
Clearly, then, the stem cells are the most important cells in the haemopoietic system. These are the cells that are essential for maintaining normal 'steady-state' haemopoiesis and also for regenerating the haemopoietic system after bone marrow transplantation or after cytotoxic therapy for malignant disease. If they are destroyed, death would rapidly result.
Furthermore, even minor perturbations in the self-renewal or differentiation of stem cells could have dramatic consequences upon the production of mature blood cells. If too many stem cells undergo differentiation, the number of stem cells would become depleted, leading initially to excess production of blood cells and eventually (when the stem cell pool becomes exhausted) to aplasia. Conversely, if stem cells undergo self-renewal in preference to differentiation, the reduced output of mature cells would be associated also with an increase in the number of stem cells, i.e. a potentially malignant condition. Indeed, perhaps the most fundamental question in cell biology is: how is the balance between self-renewal and differentiation maintained in homoeostasis in the haemopoietic and in other regenerating systems? An understanding of this process would contribute not only towards our ability to manipulate normal cells, but also, perhaps, towards appreciating how self-renewal and differentiation become 'uncoupled during tumourigenesis. While a complete understanding of this process (at the molecular level) is lacking, some clues have begun to emerge.
Haemopoietic cell growth factors: their role in stem cell differentiation
More than 25 years ago it was shown that haemopoietic progenitor cells could be induced to proliferate and develop into mature cells, if they were first immobilized in a soft-gel matrix and supplied with medium conditioned by the growth of certain non- [7, 81. They include a variety of interleukins (IL) that promote either the growth and/or the differentia-tion of T-and B-lymphocytes or their precursors (e.g. IL1-1 l), and the 'classical' CSFs promoting the development of monocytes (M) and/or neutrophils (G), e.g. GM-CSF, G-CSF and M-CSF. In addition to these factors (that directly influence the growth and differentiation of the more developmentally restricted progenitor cells), other growth factors have been described that directly influence the growth of multipotent cells. These include IL-3, IL-6 and the stem cell factor (SCF) (the recently described ligand for the c-kit proto-oncogene) Some of these growth factors have multiple target cells, while others are much more restricted.
IL-3, for example, can stimulate CFC-Mix to produce clones containing several myeloid cell lineages, and can also promote the development of bipotent and unipotent progenitor cells (GM-CFC, BFU-E, Meg-CFC, Eos-CFC) leading to the production of the appropriate mature cell types. GM-CSF on the other hand, acts only upon the GM-CFC and Eos-CFC leading to the development of neutrophils, monocytes and eosinophils; M-CSF acts upon the GM-CFC leading to the production (primarily) of monocytes/macrophages; while G-CSF and erythropoietin stimulate the generation of mature cells from neutrophil and erythroid precursor cells respectively [7] .
Superficially, these data suggest that multipotent cells have receptors for only one (e.g. IL-3) or a few of the growth factors, and that the receptors for the other growth factors are acquired during (perhaps as a consequence of) differentiation. However, this idea of sequential acquisition of receptors was subsequently shown to be naive. In a series of experiments, haemopoietic cell populations that were highly enriched for multipotential cells (and, more important, depleted of accessory cells that can produce a range of cytokines with known effects upon haemopoiesis) were exposed to recombinant, purified growth factors either alone or in combination [ 111. When these 'stem cells' were treated with single growth factors, only IL-3 was able to promote growth and differentiation: in other growth factors such as GM-CSF, G-CSF, M-CSF or IL-1, the stem cells died or showed only a modest proliferative response. This supports the data found with unseparated bone marrow cells, where the same growth factors did not promote the development of CFC-Mix. However, when some of these growth factors are combined, they can exert a powerful proliferation/differentiation stimulus on the enriched stem cell population. For example, neither G-CSF nor M-CSF can promote the sur- [7,9, 101. vival or growth of multipotent stem cells, but when the stem cells are treated with a combination of G-CSF plus M-CSF, a powerful synergistic interaction occurs, resulting in the formation of clones containing neutrophils and macrophages [ 121.
Similar synergistic interactions are seen using GM-CSF plus G-CSF and IL-3 plus IL-1. In these examples, the number of multipotential cells recruited by the growth factors is equal to, or in excess of, the number stimulated by IL-3 alone. A particularly important feature to note is that, to obtain a maximal response, the growth factors have to be added at the same time: when the stimuli are temporally separated, the response decreases with the time interval between addition of the growth factors.
A second important feature is that the outcome of the response (in terms of the mature cells produced) is a reflection of the growth factors present in the environment. In IL-3, for example, multiple myeloid cell lineages are produced, whereas in M-CSF plus G-CSF (which recruits the same cell population as that recruited by IL-3), the resulting colonies only contain neutrophils and macrophages [ l l , 121. Thus, the data suggest that multipotent stem cells possess receptors for most, if not all, of the growth factors, but a biological response is only seen with certain of the growth factors when they are used in combination.
Although the nature of the synergistic interactions seen with combinations of certain growth factors is unclear, one possibility (that we favour) is that the stem cells express only a few receptors for the appropriate ligand and that, even when all the receptors are occupied, the signals transduced are not of sufficient strength to allow either survival of the cells or stimulation of growth. Only when the growth factors are combined is a 'threshold' reached where the stem cells are recruited into a proliferative mode. A corollary of this argument is that the synergy presumably involves, at least in part, a common signal transduction system within the target cells. Data available to date (see [7] ) support this hypothesis. However, a major problem still to be resolved, is the specificity of the differentiation response in terms of the mature cells produced. Most of the biochemical events elicited by the haemopoietic cell growth factors (e.g. translocation of protein kinase C, activation of the Na+/H+ antiport, increase in primary metabolism) [7] are invariable events associated with most, if not all, growth factors and are likely to be involved more with priming of housekeeping functions, leading to mitogenesis, rather than to differential gene transcription leading to differentiation.
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Stromal-cell-mediated haemopoiesis
How then, do these growth factors work together to regulate haemopoiesis in vivo? In the bone marrow, the developing haemopoietic cells are found in intimate association with stromal cells, and overwhelming evidence suggests that the stromal cells are not simply supplying a physical matrix, but are having a direct role on proliferation/differentiation of haemopoietic cells [ 131. If haemopoietic cells and progenitor cells, for example, are cultured in vitro in the absence of added growth factors, they rapidly die through a mechanism involving apoptosis [ 14, 151. If, however, the haemopoietic cells are cultured in association with marrow stromal cells (again, in the absence of added growth factors), the stem cells undergo self-renewal and differentiation, and establish long-term haemopoiesis [13, 161 . In these cultures, homoeostasis can be maintained for several months. Thus, it can be inferred that the stromal cells are producing whatever is necessary for stem cell self-renewal, differentiation and the development of progenitor cells into mature blood cells. A particularly critical feature of stromal-cell-mediated haemopoiesis is the requirement for intimate cell contact between the stromal cells and the haemopoietic cell. If the stem cells are physically separated from the stromal cells (using a thin layer of agar or a diffusion chamber; both being systems which permit diffusion of soluble growth factors), the haemopoietic cells die [17, 181 . This suggests that appreciable levels of growth factors are not being released in a soluble form, but are 'localized' to the surface of the stromal cells where they exert their effects by cell-to-cell contact. How is this achieved? Several years ago, it was shown that molecules of the extracellular matrix of stromal cells could bind growth factors and present them, in a biologically active form, to the target haemopoietic cells [19] . In this respect, heparan sulphate proteoglycan has a particularly important role to play [ZO] . More recently, however, it has been shown that some growth factors (e.g. SCF, that is, the ligand for the receptor coded by the c-kit proto-oncogene) [ 101 may exist as proteins that span the stromal cell membrane; thus possessing an extracellular region (receptor-binding site), a transmembrane domain and an intercytoplasmic portion. In this way physical proximity between the producer cells and the target cells would be required to elicit a response. Moreover, accumulating evidence suggests that interactions between the stromal cells and the haemopoietic cells are mediated by specific celladhesion molecules [Zl] ; in the absence of cell adhesion, the haemopoietic cells are unable to respond to the stromal-cell-associated growth factors.
This raises the question of stromal cell heterogeneity. In the bone marrow, various kinds of stromal cells are present and these are characteristically found in association with specific haemopoietic cell lineages, e.g. the interaction between the reticular cells and developing granulocytes [ZZ] .
These interactions are unlikely to be trivial, and probably represent a summation of specific celladhesion molecules and presentation of the appropriate growth factors required for lineage development of haemopoietic cells. In other words, the stromal cells of the bone marrow are perhaps best seen as constituting a series of micro-environments where specific kinds of haemopoietic progenitor cells are localized (via cell-adhesion molecules), and stimulated to develop (through production and/or sequestration of growth factors, by the stromal cells) into mature blood cells. In these different environments, lineage choice and development is a reflection of the range of growth factors to which the multipotent stem cells are exposed (as discussed previously). [23] . Subsequently, we found that FDCP-Mix could be induced to undergo multilineage differentiation in liquid culture provided that the cells were supplied with IL-3, GM-CSF and G-CSF (and erythropoietin for terminal erythroid cell development). However, differentiation induction only occurred if the concentration of IL-3 was reduced from an optimal level of 50 units/ml to round about 1 unit/ml [ 121. At an IL-3 concentration of 100 unitdm1 (irrespective of the presence of other growth factors) the FDCP-Mix undergo selfrenewal in the absence of differentiation; at an IL-3 concentration of 1 unit/ml (in the presence of the other CSFs), the cells proliferate and undergo concomitant differentiation and development. Thus, although the range of growth factors to which the cells are exposed determines the choice of lineage options, the concentration of growth factors also has a major role to play in differentiation and self-renewal.
Self-renewal of stem cells
What is the mechanism whereby a high concentration of one growth factor (in this case, IL-3) can modify the response of cells to another growth factor (in this case, the developmental stimulus provided by the CSFs)? In recent work, we have shown that the numbers of cell membrane receptors for GM-CSF, when FDCP-Mix are grown in a high concentration of IL-3, is round about 20 receptors per cell with a Kd of 30 PM. Neither the number nor the affinity of these receptors change upon addition of GM-CSF, provided that the high concentration of IL-3 is maintained during culture. However, when the IL-3 concentration is reduced, the addition of GM-CSF leads to up-regulation of the number (but not the affinity) of the GM-CSF receptors on the cell membrane, reaching 70 and 700 receptors per cell on days 1 and 4 of culture, respectively. This progressive increase in the number of GM-CSF receptors is associated with the development of phenotypically (and functionally) mature cells. A possible corollary of this finding is that a high concentration of IL-3 prevents up-regulation of the receptors for GM-CSF on the cell membrane. This may indeed be the case: a recent series of experiments, again using immortalized haemopoietic cell lines, has shown that there is a concentration-dependent effect of IL-3 on the expression of c-fm (the receptor for M-CSF) on the cell membrane. In this study, the IL-3 was shown to act posttranscriptionally, at the level of RNA stability for the M-CSF receptors [ 241.
The inference drawn from these studies is that receptor 'cross-talk' plays a major determinative role in influencing both self-renewal and differentiation. Thus, in the context of stromal-cell-mediated haemopoiesis, fairly subtle differences in the concentration of growth factors present in a particular microenvironment may determine the probability of stem cells undergoing self-renewal rather than differentiation. Conversely, a minor perturbation in the ability of cells to respond to these concentration gradients is probably one of the fundamental lesions during tumourigenesis. The author's work is supported by the C.R.C.
